XOMA (XOMA) Competitor Comparison
We are evaluating the key criteria listed to compare XOMA (XOMA) against its competitors in the Biotechnology industry.
Market Capitalization
208 / 368Gross Profits
107 / 278Total Revenue
204 / 300EBITDA
92 / 337Free Cashflow
36 / 352Quick Ratio
253 / 357Earnings per Share
223 / 359Dividend yield
3 / 6Total Cash
281 / 358Performance 3 years
81 / 368Performance 5 years
112 / 368Performance 10 years
168 / 368Linearity 3 years
35 / 368Linearity 5 years
48 / 368Linearity 10 years
186 / 368Total Rank
72 / 368Dividend Rank
11 / 368Valuation Rank
314 / 368Piotroski Rank
183 / 368Muliplier Rank
243 / 368Performance 10 years - XOMA ranking 168 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.